Research Article
The Diagnosis of Invasive and Noninvasive Pulmonary Aspergillosis by Serum and Bronchoalveolar Lavage Fluid Galactomannan Assay
Table 3
Analysis of factors contributing to false-positives in the BALF-GM assay.
| | False positive () | Negative () | |
| Age | 60 (26–86) | 59 (20–92) | 0.609 | Gender (male/female) | 18/17 | 29/29 | 0.894 | Host factors | 15 (42.8%) | 29 (50.0%) | 0.367 | Cefepime | 5 (14.3%) | 4 (6.9%) | 0.289 | Cefoperazone-sulbactam | 7 (20.0%) | 13 (22.4%) | 0.784 | Piperacillin-sulbactam | 2 (5.7%) | 2 (3.4%) | 0.630 | Piperacillin-tazobactam | 2 (5.7%) | 4 (6.9%) | 1 | Meropenem | 4 (11.4%) | 6 (10.3%) | 1 | Fluoroquinolones | 10 (28.6%) | 8 (13.8%) | 0.081 | Candida sp. colonization | 8 (22.9%) | 9 (15.5%) | 0.375 | Coinfected with Pneumocystis jirovecii | 7 (20%) | 2 (3.4%) | 0.024 |
|
|